Please use this identifier to cite or link to this item:
Title: Palmitoylethanolamide and polydatin effect on pain and dysmenorrhea in women scheduled for laparoscopic treatment of possible endometriosis: a double blind randomised controlled trial.
Epworth Authors: Amir, Michal
Readman, Emma
Ellett, Lenore
Mooney, Samantha
Hicks, Lauren
Healey, Martin
Other Authors: Reddington, Charlotte
Cheng, Claudia
Harlow, Keryn
Ross, Vanessa
Holdsworth-Carson, Sarah
Donoghue, Jacqueline
Teague, Stephanie
Rogers, Peter
Keywords: Endometriosis
Pelvic Pain
Food Supplements
Issue Date: Oct-2023
Conference Name: Epworth HealthCare Research Month 2023
Conference Location: Epworth Research Institute, Victoria, Australia
Abstract: Endometriosis effects at least 10% of reproductive age females worldwide; Effective medical therapies for the treatment of endometriosis related pelvic pain are limited and are often associated with side-effects. Palmitoylethanolamide (PEA) is a food supplement that has been shown to have anti-inflammatory action. Polydatin (PLD) is also a food supplement that has antioxidant and pain inhibiting activities. There have been some small studies performed to assess if the combination of PEA/PLD is helpful for persistent pain associated with endometriosis. The results suggest it might have benefit, but further studies are required.
Type: Conference Poster
Affiliated Organisations: Department of Obstetrics and Gynaecology University of Melbourne, Parkville, Australia
Gynaecology 2 Royal Women’s Hospital, Carlton, Australia
Endosurgery A and B Units Mercy Hospital for Women, Heidelberg, Australia
Type of Clinical Study or Trial: Double-Blinded randomised Controlled Trial
Appears in Collections:Research Month

Files in This Item:
File Description SizeFormat  
Epworth Research Month 2023_PEA PLD Poster final_Michal_Amir.pdf649.79 kBAdobe PDFThumbnail

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.